Search Results - Gudin, Jeff

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Utility of lidocaine as a topical analgesic and improvements in patch delivery systems

    Utility of lidocaine as a topical analgesic and improvements in patch delivery systems by Gudin, Jeff, Nalamachu, Sri

    Published in Postgraduate medicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain

    Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain by Gudin, Jeff

    Published in Pain and therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Oxycodone DETERx super( registered ): A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain

    Oxycodone DETERx super( registered ): A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain by Gudin, Jeff

    Published in Pain and therapy
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Poster 523 Sensitivity Analyses of Secondary Daytime and Nighttime Pain Intensity Endpoints in a Phase 2 Randomized, Placebo-controlled Study of Gabapentin Enacarbil (GEn) in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia (PHN)

    Poster 523 Sensitivity Analyses of Secondary Daytime and Nighttime Pain Intensity Endpoints in a Phase 2 Randomized, Placebo-controlled Study of Gabapentin Enacarbil (GEn) in Patie... by Calkins, Anne, Gudin, Jeff, MD, Gidal, Barry E., PharmD, RPh, Jaros, Mark J., PhD, Kim, Richard, Shang, Gwendoline Y., MD

    Published in PM & R
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Poster 524 Sensitivity Analyses of the Primary Efficacy Endpoint in a Phase 2 Randomized, Placebo-controlled Study of Gabapentin Enacarbil (GEn) in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia (PHN)

    Poster 524 Sensitivity Analyses of the Primary Efficacy Endpoint in a Phase 2 Randomized, Placebo-controlled Study of Gabapentin Enacarbil (GEn) in Patients with Neuropathic Pain A... by Calkins, Anne, Gudin, Jeff, MD, Gidal, Barry E., PharmD, RPh, Jaros, Mark J., PhD, Kim, Richard, Shang, Gwendoline Y., MD

    Published in PM & R
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain

    SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain by Argoff, Charles, McCarberg, Bill, Gudin, Jeff, Nalamachu, Srinivas, Young, Clarence

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties

    Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended‐Release Oxycodone Formulations with Abuse‐Deterrent Properties by Gudin, Jeff, Levy‐Cooperman, Naama, Kopecky, Ernest A., Fleming, Alison B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    The Downside of Upscheduling

    The Downside of Upscheduling by Gudin, Jeff, Lee, Anna J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Response to Crudele et al. Commentary on Gudin et al. “Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties”

    Response to Crudele et al. Commentary on Gudin et al. “Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Ab... by Gudin, Jeff, Kopecky, Ernest A., Fleming, Alison B.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  10. 10
    Impact of Data Imputation Methodology on Pain Assessment over 24Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia

    Impact of Data Imputation Methodology on Pain Assessment over 24Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated... by Calkins, Anne M, Gudin, Jeff, Gidal, Barry, Jaros, Mark J, Kim, Richard, Shang, Gwendoline

    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia

    Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associate... by Calkins, Anne M., Gudin, Jeff, Gidal, Barry, Jaros, Mark J., Kim, Richard, Shang, Gwendoline

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  12. 12
    Oxycodone DETERx^sup ^: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain

    Oxycodone DETERx^sup ^: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain by Gudin, Jeff

    Published in Pain and Therapy
    Get full text
    Review
    Save to List
    Saved in:

Search Tools: